Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen.
Acute invasive pulmonary aspergillosis occurs predominantly in immunocompromised hosts, with increasing numbers of cases of invasive aspergillosis among patients with chronic obstructive pulmonary disease (COPD) being reported. Among 13 cases of invasive aspergillosis diagnosed in COPD patients admitted to the intensive care unit with acute respiratory distress, the only risk factor for invasive fungal infection was corticosteroid treatment. Invasive aspergillosis should be suspected in COPD patients receiving steroid treatment who have extensive pulmonary infiltrates. Survival depends on rapid diagnosis and early appropriate treatment. A decrease or interruption of steroid treatment should be considered as part of the overall therapeutic strategy.
Ader
F
F
Service de Réanimation Médicale et Maladies Infectieuses, CH de Tourcoing, Tourcoing, France. fader@ch-tourcoing.fr
Nseir
S
S
Le Berre
R
R
Leroy
S
S
Tillie-Leblond
I
I
Marquette
C H
CH
Durocher
A
A
D001228:Aspergillosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000188:drug therapy; D012307:Risk Factors; D028761:Withholding Treatment
D005938:Glucocorticoids